| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.105.606962 |
| P698 | PubMed publication ID | 16735683 |
| P50 | author | Kevin Jon Williams | Q39184621 |
| P2093 | author name string | Ira Tabas | |
| P433 | issue | 21 | |
| P921 | main subject | hypothesis | Q41719 |
| P304 | page(s) | e782; author reply e783 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Letter by Williams and Tabas regarding article "atherosclerosis 2005: recent discoveries and novel hypotheses" | |
| P478 | volume | 113 |
| Q57085353 | 24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study |
| Q26801287 | A Review of Nebivolol Pharmacology and Clinical Evidence |
| Q53395015 | A comparison between central blood pressure values obtained by the Gaon system and the SphygmoCor system. |
| Q88154544 | Abnormal pressure-wave reflection in pregnant women with chronic hypertension: association with maternal and fetal outcomes |
| Q60594034 | Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients |
| Q92461009 | Adverse influence of bisoprolol on central blood pressure in the upright position: a double-blind placebo-controlled cross-over study |
| Q47411824 | Aortic size index enlargement is associated with central hemodynamics in essential hypertension |
| Q37775515 | Arterial aging--hemodynamic changes and therapeutic options |
| Q82269087 | Arterial stiffening in hypertension: beyond blood pressure levels |
| Q50097038 | Arterial stiffness as a risk factor for clinical hypertension |
| Q81352135 | Arterial stiffness: beyond pulse wave velocity and its measurement |
| Q48498137 | Association between central systolic blood pressure, white matter lesions in cerebral MRI and carotid atherosclerosis |
| Q53393062 | Association of left ventricular diastolic dysfunction with 24-h aortic ambulatory blood pressure: the SAFAR study. |
| Q50589805 | Associations of central and brachial blood pressure with cognitive function: a population-based study. |
| Q101121232 | Associations of central and peripheral blood pressure with the renin-angiotensin-aldosterone system in healthy young adults: the African-PREDICT study |
| Q47903477 | Augmentation index is associated with B-type natriuretic peptide in patients with paroxysmal atrial fibrillation |
| Q86618852 | Blood pressure and arterial stiffness in patients with high sodium intake in relation to sodium handling and left ventricular diastolic dysfunction status |
| Q84554413 | Calibration mode influences central blood pressure differences between SphygmoCor and two newer devices, the Arteriograph and Omron HEM-9000 |
| Q60593873 | Cardiovascular prevention: relationships between arterial aging and chronic drug treatment |
| Q83752040 | Cardiovascular prevention: relationships between arterial aging and chronic drug treatment |
| Q47841171 | Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial. |
| Q83380547 | Central aortic blood pressure and augmentation index during normal pregnancy |
| Q100635903 | Central aortic pressure and long-term outcome in hypertensive patients undergoing percutaneous coronary intervention |
| Q86766030 | Central blood pressure estimation by using N-point moving average method in the brachial pulse wave |
| Q47597891 | Central blood pressure measurement may improve risk stratification |
| Q96577028 | Central blood pressure predicts the development of hypertension in the general population |
| Q84770890 | Central blood pressure, arterial stiffness and the heart in hypertensive patients |
| Q61633716 | Central-to-brachial blood pressure amplification in type 2 diabetes: a systematic review and meta-analysis |
| Q44276863 | Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study |
| Q39103506 | Clinical roles of calcium channel blockers in ischemic heart diseases |
| Q51857073 | Clinical usefulness of the second peak of radial systolic blood pressure for estimation of aortic systolic blood pressure. |
| Q54390449 | Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients. |
| Q87407665 | Comparison of the efficacy between hydrochlorothiazide and chlorthalidone on central aortic pressure when added on to candesartan in treatment-naïve patients of hypertension |
| Q83380554 | Comparison of two measuring instruments, B-pro and SphygmoCor system as reference, to evaluate central systolic blood pressure and radial augmentation index |
| Q45182782 | Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study |
| Q48182447 | Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population. |
| Q33801951 | Differential response of central blood pressure to isometric and isotonic exercises |
| Q44740994 | Distribution of central blood pressure values estimated by Omron HEM-9000AI in the Japanese general population |
| Q61863492 | Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study |
| Q33895481 | Dynamic whole-body vibration training: a unique upstream treatment from the muscle to the arterial system and central hemodynamics |
| Q47578330 | Effect of weight loss on central systolic blood pressure in elderly community-dwelling persons |
| Q46877368 | Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial |
| Q79817369 | Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients |
| Q44582608 | Effects of antihypertensive drugs on central blood pressure: new evidence, more challenges |
| Q43284477 | Effects of hydroxyhydroquinone-reduced coffee on vasoreactivity and blood pressure |
| Q46671693 | Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study |
| Q82743670 | Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients |
| Q49570844 | Elevated pulse amplification in hypertensive patients with advanced kidney disease |
| Q83910688 | Estimation of central systolic blood pressure using an oscillometric blood pressure monitor |
| Q91198683 | Evidence of Cardiovascular Calcification and Fibrosis in Pseudoxanthoma Elasticum Mouse Models Subjected to DOCA-Salt Hypertension |
| Q38130624 | Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease. |
| Q51734312 | Heart rate reduction decreases central blood pressure in sick sinus syndrome patients with a permanent cardiac pacemaker. |
| Q37868929 | Heart rate: a forgotten link in coronary artery disease? |
| Q92643895 | High-intensity interval training for reducing blood pressure: a randomized trial vs. moderate-intensity continuous training in males with overweight or obesity |
| Q59792776 | Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention |
| Q43051939 | Hypertension: antihypertensive class matters for combination therapy |
| Q50934668 | Impact of the augmentation time ratio on direct measurement of central aortic pressure in the presence of coronary artery disease. |
| Q24619354 | Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients |
| Q60594031 | Incremental value of arterial wave reflections in the determination of left ventricular diastolic dysfunction in untreated patients with essential hypertension |
| Q85948295 | Is validation of non-invasive hemodynamic measurement devices actually required? |
| Q52900962 | Isolated systolic hypertension. An independent disease |
| Q49830280 | Joint Effect of Non-invasive Central Systolic Blood Pressure and Peripheral Systolic Blood Pressure on Incident Hypertension in a Chinese Community-based Population |
| Q37176037 | Macro and microvasculature in hypertension: therapeutic aspects |
| Q59309055 | Monitoring of the central blood pressure waveform via a conformal ultrasonic device |
| Q57551553 | More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension |
| Q90370835 | Multiscale mathematical modeling vs. the generalized transfer function approach for aortic pressure estimation: a comparison with invasive data |
| Q90765688 | Noninvasive central systolic blood pressure, not peripheral systolic blood pressure, independently predicts the progression of carotid intima-media thickness in a Chinese community-based population |
| Q38796954 | Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction |
| Q53152486 | Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients. |
| Q84242814 | Preferential association of aldosterone synthase gene polymorphism with central blood pressure and wave reflections in hypertensive individuals |
| Q36633983 | Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk |
| Q37384710 | Protective effects of renin-angiotensin blockade beyond blood pressure control. |
| Q57396155 | Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia—the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) |
| Q82603690 | Pulse wave analysis and pulse wave velocity techniques: are they ready for the clinic? |
| Q91283934 | Relationship between sleep-disordered breathing and central systolic blood pressure in a community-based population: the Toon Health Study |
| Q38115114 | Renal sympathetic denervation: applications in hypertension and beyond. |
| Q57085396 | Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs |
| Q38850818 | Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients |
| Q43575202 | Significance of the second peak of systolic blood pressure for identifying both high and low cardiovascular risk states |
| Q51620241 | Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population. |
| Q85948290 | Subservient relationship of the peripheral second systolic pressure peak to the central hemodynamic parameters is preserved, irrespective of atherosclerosis progression in hypercholesterolemic rabbits |
| Q83429755 | Synergistic effect of smoking and blood pressure on augmentation index in men, but not in women |
| Q81352130 | Targeting the arterial wall, but what is the target? |
| Q37807824 | The Cardiovascular Continuum extended: Aging effects on the aorta and microvasculature |
| Q37804394 | The Combined Effect of Hypertension and Smoking on Arterial Stiffness |
| Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
| Q37741783 | The RAAS in the pathogenesis and treatment of diabetic nephropathy |
| Q43053406 | The effect of p22(phox) -930A/G, A640G and C242T polymorphisms of NADPH oxidase on peripheral and central pressures in healthy, normotensive individuals |
| Q36575410 | Towards improving the clinical assessment and management of human hypertension: An overview from this Journal |
| Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
Search more.